0001493152-23-004168.txt : 20230209 0001493152-23-004168.hdr.sgml : 20230209 20230209201150 ACCESSION NUMBER: 0001493152-23-004168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230209 FILED AS OF DATE: 20230209 DATE AS OF CHANGE: 20230209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DelAversano Robert J CENTRAL INDEX KEY: 0001728262 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54318 FILM NUMBER: 23608085 MAIL ADDRESS: STREET 1: 217 W. MAIN STREET CITY: SOMERVILLE STATE: NJ ZIP: 08876 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc CENTRAL INDEX KEY: 0001444307 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980573252 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 820 BEAR TAVERN ROAD CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: (858) 210-7333 MAIL ADDRESS: STREET 1: 820 BEAR TAVERN ROAD CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: NetVentory Solutions, Inc. DATE OF NAME CHANGE: 20080902 4 1 ownership.xml X0306 4 2023-02-09 0 0001444307 ONCOSEC MEDICAL Inc ONCS 0001728262 DelAversano Robert J C/O ONCOSEC MEDICAL INCORPORATED 24 NORTH MAIN STREET PENNINGTON NJ 08534 0 1 0 0 VP, Finance Common Stock 2023-02-09 4 S 0 40 1.37 D 1008 D In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies. Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22. /s/ Robert J. DelAversano 2023-02-09